Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men

Correction to: A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men

The article [A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer chemotherapy and pharmacology 2018-02, Vol.81 (2), p.419-419
Hauptverfasser: Markus, Richard, Chow, Vincent, Pan, Zhiying, Hanes, Vladimir
Format: Artikel
Sprache:eng
Schlagworte:
Androgens
Bevacizumab
Cancer Research
Correction
Medicine
Medicine & Public Health
Oncology
Pharmacology
Pharmacology/Toxicology
Randomization
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The article [A phase I, randomized, single-dose study evaluating the pharmacokinetic equivalence of biosimilar ABP 215 and bevacizumab in healthy adult men]
ISSN:0344-5704
1432-0843
DOI:10.1007/s00280-017-3457-8